DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Masonic Cancer Center, University of Minnesota
University of Washington
OHSU Knight Cancer Institute
Alliance for Clinical Trials in Oncology
Memorial Sloan Kettering Cancer Center